This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mogam Biotechnology Institute. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Dong Ho Ahn
Introduction
Dong Ho Ahn is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of cell lines for vaccine production. His work focuses on enhancing the efficiency and safety of viral vaccine production.
Latest Patents
Dong Ho Ahn holds a patent for a novel MDCK-derived cell strain that is suspension-cultured in a protein-free medium. This invention relates to a method for proliferating viruses using the MDCK-derived cell line to produce vaccines. The cell line exhibits high and uniform productivity for various viruses, while minimizing viral antigenic variations and demonstrating low tumorigenicity. This innovation is crucial for producing viruses used in vaccines.
Career Highlights
Ahn is associated with the Mogam Biotechnology Institute, where he continues to advance research in biotechnology. His work has been instrumental in developing safer and more effective methods for vaccine production.
Collaborations
He collaborates with notable colleagues, including Mihee Hwang and Kukjin Park, who contribute to his research endeavors.
Conclusion
Dong Ho Ahn's innovative work in biotechnology, particularly in vaccine production, showcases his commitment to advancing medical science. His contributions are vital for the future of vaccine development and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile